BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28040716)

  • 1. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
    Daly MB; Pilarski R; Berry M; Buys SS; Farmer M; Friedman S; Garber JE; Kauff ND; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Merajver SD; Offit K; Pal T; Reiser G; Shannon KM; Swisher E; Vinayak S; Voian NC; Weitzel JN; Wick MJ; Wiesner GL; Dwyer M; Darlow S
    J Natl Compr Canc Netw; 2017 Jan; 15(1):9-20. PubMed ID: 28040716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
    Daly MB; Pilarski R; Yurgelun MB; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Garber JE; Goggins M; Hutton ML; Khan S; Klein C; Kohlmann W; Kurian AW; Laronga C; Litton JK; Mak JS; Menendez CS; Merajver SD; Norquist BS; Offit K; Pal T; Pederson HJ; Reiser G; Shannon KM; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Dwyer MA; Darlow SD
    J Natl Compr Canc Netw; 2020 Apr; 18(4):380-391. PubMed ID: 32259785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
    Kotnik U; Peterlin B; Lovrecic L
    BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
    Daly MB; Pilarski R; Axilbund JE; Berry M; Buys SS; Crawford B; Farmer M; Friedman S; Garber JE; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Marcom PK; Merajver SD; Offit K; Pal T; Rana H; Reiser G; Robson ME; Shannon KM; Swisher E; Voian NC; Weitzel JN; Whelan A; Wick MJ; Wiesner GL; Dwyer M; Kumar R; Darlow S
    J Natl Compr Canc Netw; 2016 Feb; 14(2):153-62. PubMed ID: 26850485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and management of familial breast cancer in Austria.
    Singer CF; Tan YY; Rappaport C
    Horm Mol Biol Clin Investig; 2017 Nov; 32(2):. PubMed ID: 29190211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.
    Gupta S; Provenzale D; Regenbogen SE; Hampel H; Slavin TP; Hall MJ; Llor X; Chung DC; Ahnen DJ; Bray T; Cooper G; Early DS; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Markowitz AJ; Mayer RJ; Ness RM; Samadder NJ; Shike M; Sugandha S; Weiss JM; Dwyer MA; Ogba N
    J Natl Compr Canc Netw; 2017 Dec; 15(12):1465-1475. PubMed ID: 29223984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
    Benson AB; D'Angelica MI; Abbott DE; Abrams TA; Alberts SR; Saenz DA; Are C; Brown DB; Chang DT; Covey AM; Hawkins W; Iyer R; Jacob R; Karachristos A; Kelley RK; Kim R; Palta M; Park JO; Sahai V; Schefter T; Schmidt C; Sicklick JK; Singh G; Sohal D; Stein S; Tian GG; Vauthey JN; Venook AP; Zhu AX; Hoffmann KG; Darlow S
    J Natl Compr Canc Netw; 2017 May; 15(5):563-573. PubMed ID: 28476736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
    Benson AB; D'Angelica MI; Abbott DE; Abrams TA; Alberts SR; Anaya DA; Anders R; Are C; Brown D; Chang DT; Cloyd J; Covey AM; Hawkins W; Iyer R; Jacob R; Karachristos A; Kelley RK; Kim R; Palta M; Park JO; Sahai V; Schefter T; Sicklick JK; Singh G; Sohal D; Stein S; Tian GG; Vauthey JN; Venook AP; Hammond LJ; Darlow SD
    J Natl Compr Canc Netw; 2019 Apr; 17(4):302-310. PubMed ID: 30959462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    Stuckey AR; Onstad MA
    Am J Obstet Gynecol; 2015 Aug; 213(2):161-5. PubMed ID: 25747548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement.
    Am Fam Physician; 2020 Feb; 101(4):233-238. PubMed ID: 32053325
    [No Abstract]   [Full Text] [Related]  

  • 11. Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario.
    Dos Santos Vidal R; Hawrysh A; Walia JS; Davey S; Feilotter H
    J Mol Diagn; 2016 May; 18(3):362-369. PubMed ID: 26941049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
    Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
    Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal genetic counseling practices regarding recommendations for cancer genetic counseling: A retrospective chart review from two academic institutions.
    Saba LF; Sullivan CM; Solomon T; Huguenard S; Nassef SA
    J Genet Couns; 2022 Oct; 31(5):1062-1070. PubMed ID: 35434961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA;
    J Natl Compr Canc Netw; 2013 May; 11(5):519-28. PubMed ID: 23667203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal Cancer, Version 2.2015.
    Benson AB; Venook AP; Bekaii-Saab T; Chan E; Chen YJ; Cooper HS; Engstrom PF; Enzinger PC; Fenton MJ; Fuchs CS; Grem JL; Grothey A; Hochster HS; Hunt S; Kamel A; Kirilcuk N; Leong LA; Lin E; Messersmith WA; Mulcahy MF; Murphy JD; Nurkin S; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Gregory KM; Freedman-Cass D
    J Natl Compr Canc Netw; 2015 Jun; 13(6):719-28; quiz 728. PubMed ID: 26085388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Perils of Single-Site Genetic Testing for Hereditary Cancer Syndromes in the Era of Next-Generation Sequencing.
    Casasanta N; Stark E; McHenry A; Biagi T; Kaltman R
    Oncologist; 2018 Apr; 23(4):393-396. PubMed ID: 29445031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Daly MB; Pal T; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Goggins M; Hutton ML; ; Karlan BY; Khan S; Klein C; Kohlmann W; ; Kurian AW; Laronga C; Litton JK; Mak JS; ; Menendez CS; Merajver SD; Norquist BS; Offit K; Pederson HJ; Reiser G; ; Senter-Jamieson L; ; Shannon KM; Shatsky R; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Yurgelun MB; Darlow SD; Dwyer MA
    J Natl Compr Canc Netw; 2021 Jan; 19(1):77-102. PubMed ID: 33406487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCN GuidelinesĀ® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
    Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
    J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.